Is high-sensitivity troponin, alone or in combination with copeptin, sensitive enough for ruling out NSTEMI in very early presenters at admission? A post hoc analysis performed in emergency departments

MLA

Nicolas Peschanski, et al. “Is High-Sensitivity Troponin, Alone or in Combination with Copeptin, Sensitive Enough for Ruling out NSTEMI in Very Early Presenters at Admission? A Post Hoc Analysis Performed in Emergency Departments.” BMJ Open, vol. 9, no. 6, June 2019. EBSCOhost, https://doi.org/10.1136/bmjopen-2018-023994.

APA

Nicolas Peschanski, Camille Chenevier-Gobeaux, Mustapha Sebbane, Christophe Meune, Sophie Lefebvre, Anne-Marie Dupuy, Guillaume Lefèvre, & Patrick Ray. (2019). Is high-sensitivity troponin, alone or in combination with copeptin, sensitive enough for ruling out NSTEMI in very early presenters at admission? A post hoc analysis performed in emergency departments. BMJ Open, 9(6). https://doi.org/10.1136/bmjopen-2018-023994

Chicago

Nicolas Peschanski, Camille Chenevier-Gobeaux, Mustapha Sebbane, Christophe Meune, Sophie Lefebvre, Anne-Marie Dupuy, Guillaume Lefèvre, and Patrick Ray. 2019. “Is High-Sensitivity Troponin, Alone or in Combination with Copeptin, Sensitive Enough for Ruling out NSTEMI in Very Early Presenters at Admission? A Post Hoc Analysis Performed in Emergency Departments.” BMJ Open 9 (6). doi:10.1136/bmjopen-2018-023994.